Inventurus Knowledge Solutions Limited has successfully completed its comprehensive investment plan in wholly owned subsidiary IKS Inc, with the latest regulatory filing dated April 2, 2026, confirming the conclusion of the second and final tranche. The company has now invested a total of approximately USD 40 million across both investment phases.

Investment Completion Details

The company announced the completion of its second tranche investment in Inventurus Knowledge Solutions, Inc. (IKS Inc.), marking the conclusion of the investment plan initially approved by the Board on March 13, 2026.

Regulatory Compliance Framework

The investment follows a structured regulatory disclosure process under SEBI LODR Regulations. The company maintained transparency through multiple filings, starting with the Board approval disclosure on March 13, 2026, followed by the first tranche completion on March 27, 2026, and concluding with the final tranche completion on April 2, 2026.

All disclosures were made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, with both BSE and NSE being formally notified at each stage of the investment process.

Strategic Investment Significance

This substantial USD 40 million investment represents Inventurus Knowledge Solutions' significant commitment to strengthening its US-based subsidiary operations. The acquisition of over 62,000 shares demonstrates the company's strategic focus on expanding its subsidiary's capabilities and market presence.

The completion of this two-phase investment plan positions IKS Inc. for enhanced operational capacity and growth potential within the Inventurus Knowledge Solutions ecosystem. Company Secretary and Compliance Officer Sameer Chavan executed both tranches, ensuring proper documentation and regulatory compliance throughout the entire investment process.

Inventurus Knowledge Solutions Limited has announced a strategic acquihire that significantly expands its AI capabilities in healthcare operations. Through its subsidiary IKS Health, the company has acquired ThinkDTM, an AI-native product, strategy, and digital services company, marking a key step in strengthening its patient access solutions portfolio.

Strategic Leadership Addition

The acquihire brings ThinkDTM Founder Tij Bedi into IKS Health as Executive Vice President and General Manager, Patient Access and Innovation. Bedi's established team of AI technology experts will integrate into IKS Health's operations, bringing specialized expertise in artificial intelligence implementation.

"As healthcare continues to be disrupted, joining IKS Health is a tremendous opportunity to intelligently implement AI in ways that make patients' lives easier," Bedi commented on the acquisition.

Expansion of Patient Access Solutions

The newly expanded team will focus on transforming IKS Health's patient access solutions portfolio across multiple areas:

• Patient scheduling systems
• Registration processes
• Demographic capture capabilities
• Insurance eligibility verification
• Prior authorization workflows

The integration aims to build and scale differentiated patient access solutions while strengthening platform capabilities and driving innovation that enhances outcomes for both healthcare providers and patients.

Strategic AI Implementation

Sachin K. Gupta, Founder and Global CEO of IKS Health, emphasized the strategic importance of the acquisition in the company's AI development. "Tij and his team are critical additions to our growing team of AI engineers and experts, particularly as we lean into the world of agentic AI and its role in our continued growth and scale in revenue optimization and beyond," Gupta stated.

The acquisition positions IKS Health to leverage agentic AI workflows combined with human expertise to create more accurate operations and better outcomes across the healthcare journey.

Company Background and Recognition

IKS Health operates as a global leader in care enablement solutions, focusing on reducing administrative, clinical, and operational burdens in healthcare. The company has received multiple industry recognitions:

Inventurus Knowledge Solutions Limited trades on both the National Stock Exchange of India Limited and BSE Limited, positioning the company in the public markets as it expands its healthcare technology capabilities through strategic acquisitions like ThinkDTM.